Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 563 results for "ranbaxy laboratories"

No Meal Required Isotretinoin Capsules on the Market
MedEsthetics Magazine

Ranbaxy launches ABSORICA in the US

Ranbaxy Laboratories has launched ABSORICA (isotretinoin) 25 mg and 35 mg capsules into the US healthcare market. ABSORICA has become the most prescribed branded oral isotretinoin in the US, as per a recent independent survey conducted with ... Express Pharma, 2 hours ago
[x]  
NDTV Profit

Merger with Sun Pharma: Ranbaxy moves HC for nod

Moving closer to finalising the biggest merger of two Indian medicine companies, Ranbaxy Laboratories has moved the Punjab and Haryana high court to get sanction for its scheme of amalgamation with Sun Pharmaceuticals. Taking up the petition of ...
 Hindustan Times8 hours ago No CCI directive to sell business for merger nod with Sun Pharma: Ranbaxy  Economic Times4 days ago No CCI directive to sell biz for merger nod with Sun: Ranbaxy  Business Standard4 days ago 'No CCI directive to sell biz for merger nod with Sun'  Business Today India4 days ago
Rediff.com

Ranbaxy staff get pay-cut shield in Sun buyout

The agreement agreed to by Sun Pharmaceutical Industries for a buyout of Ranbaxy Laboratories from Daiichi Sankyo provides for a year's 'cooling period' during which the pay of Ranbaxy employees cannot be lowered, it is learnt. Ranbaxy is said to have also budgeted around Rs 65 crore for a retention bonus and identified 70-75 executives to distribute this. The year's cooling period is expected to start from the completion of the transaction between Sun and Daiichi, a source said. Ranbaxy ...
 Rediff.com1 day ago Ranbaxy Laboratories??? Staff Get Pay-Cut Shield In Sun Pharmaceutical Industries Ltd Buyout  BioSpace19 hours ago
Business Standard India

RANBAXY LABORATORIES : to pay $40m to settle US case

MUMBAI : Ranbaxy has agreed to settle a case regarding its participation in Texas Medicaid, the US federal-state healthcare plan. Under the settlement agreement, Ranbaxy will make payments to the state of Texas totaling $39.75 million in a series of ...
 4 Traders2 days ago Ranbaxy Laboratories : TO PAY $40 MILLION TO TEXAS FOR SETTLEMENT OF MEDICAID PRICING LITIGATION  4 Traders1 day ago Ranbaxy to pay Texas $40 mn to settle litigation  Business Standard India4 days ago Ranbaxy buys Texas peace  The Telegraph4 days ago
[x]  

Ranbaxy Laboratories: Updates on termination of GDR programme

Ranbaxy Laboratories Ltd has informed BSE that the Company has notified the Bank of New York Mellon (hereinafter R anbaxy Laboratories Ltd has informed BSE that the Company has notified the Bank of New York Mellon (hereinafter "The Bank") to ...
 Moneycontrol.com5 days ago Ranbaxy Laboratories allots equity shares  Business Standard1 week ago Ranbaxy Laboratories' Q2 results on October 28, 2014  Money Control3 weeks ago Ranbaxy Laboratories: Outcome of court convened meeting of equity shareholders  Money Control3 weeks ago

Competition Commission of India may okay Sun-Ranbaxy deal with rider

By Rajat Arora NEW DELHI: Sun Pharma and Ranbaxy Laboratories may have to give price and supply commitments, which include ensuring price caps on some drugs for a specific period, before the (CCI) gives its approval to their proposed merger. The ...
 Economic Times3 days ago Ranbaxy Laboratories : Competition Commission of India may okay Sun-Ranbaxy deal with rider  4 Traders19 hours ago
[x]  
Business Standard India

RANBAXY'S TOP EXECUTIVES IN THE US RESIGN

R (Indian Business Insight Via Acquire Media NewsEdge) Top executives of Ranbaxy Inc., the US subsidiary of Ranbaxy Laboratories of India, have left the company in the past two weeks. The executives who have left the company include country head ...
 TMC Net5 days ago Top Ranbaxy executives resign in US  Business Standard India1 week ago
[x]  

Ranbaxy Laboratories : US subsidiary sees 5 top-level exits including boss Venkat Krishnan

NEW DELHI : At least five senior executives of the US arm of Ranbaxy Laboratories , including its top boss Venkat Krishnan , have tendered their resignations or are planning to quit soon, people familiar with the matter said. Some of them are ...
 4 Traders2 days ago Ranbaxy's US subsidiary sees 5 top-level exits including boss Venkat Krishnan  Times of India1 week ago
Business Standard India

Sun, Ranbaxy may be asked to sell some businesses for CCI approval to merger

Sushmi Dey & Nivedita Mookerji | New Delhi October 15, 2014 Last Updated at 00:57 IST Ranbaxy Laboratories and Sun Pharmaceutical Industries are likely to be advised to sell parts of their businesses before the Competition Commission of India (CCI) ...
 Business Standard India6 days ago

Ranbaxy Laboratories trades with traction on the BSE

Ranbaxy Laboratories is currently trading at Rs. 611.60, up by 7.15 points or 1.18% from its previous closing of Rs. 604.45 on the BSE. The scrip opened at Rs. 601.50 and has touched a high and low of Rs. 619.00 and Rs. 593.00 respectively. So far ...
 Indian-Commodity1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - ranbaxy laboratories
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less